Status and phase
Conditions
Treatments
About
The objective of the present study is to obtain information about the safety, tolerability and pharmacokinetics of BIBN 4096 BS after single intranasal administration of increasing doses in healthy male and female volunteers
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
For female subjects:
Primary purpose
Allocation
Interventional model
Masking
38 participants in 2 patient groups, including a placebo group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal